CDK4/6 inhibition alone and in combination for non-small cell lung cancer

Oncotarget. 2019 Jan 18;10(6):618-619. doi: 10.18632/oncotarget.26545.

Authors

Jose Pacheco^{1

1}, Erin Schenk^{1

1}

Affiliation

¹ University of Colorado Cancer Center, Aurora, CO, USA.

No abstract available

Keywords: CDK4/6; MEK/ERK; NSCLC; mTOR; palbociclib.

Publication types

News
Comment